Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million

GlobeNewswire
2025.10.22 12:04

Galera Therapeutics 宣佈多倫多的 Biossil 以高達 1.05 億美元收購 Avasopasem 及其超氧化物歧化酶模擬物組合

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.